Empresa Black Diamond Therapeutics, Inc. OTC Markets
Acciones
BDTX
US09203E1055
Biotecnología e investigación médica
Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
- USD | -.--% | -.--% | -.--% |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 01/01/14 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 09/08/21 |
David Epstein
FOU | Founder | 65 | 01/01/14 |
Fang Ni
DFI | Director of Finance/CFO | 37 | 04/08/20 |
Sergey Yurasov
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/06/22 |
Chief Operating Officer | 59 | 29/05/19 | |
Julie Seidel
IRC | Investor Relations Contact | - | - |
Melanie Morrison
PRN | Corporate Officer/Principal | - | 01/10/22 |
Human Resources Officer | 52 | 22/02/22 | |
Erika Jones
AUD | Comptroller/Controller/Auditor | 39 | 01/10/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 01/01/14 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 09/08/21 |
Ali Behbahani
BRD | Director/Board Member | 48 | 01/12/18 |
Garry Menzel
BRD | Director/Board Member | 59 | 01/01/14 |
Kapil Dhingra
BRD | Director/Board Member | 64 | 19/01/21 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 01/12/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 56 252 794 | 54 935 052 ( 97,66 %) | 0 | 97,66 % |
Información de la empresa
Black Diamond Therapeutics, Inc.
One Main Street 14th floor
02142, Cambridge
+
http://www.blackdiamondtherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+12,30 % | 118 mil M | |
+12,15 % | 106 mil M | |
-8,14 % | 23,4 mil M | |
-1,69 % | 21,78 mil M | |
-10,60 % | 18,09 mil M | |
-41,25 % | 16,72 mil M | |
-15,33 % | 15,97 mil M | |
+5,80 % | 14,03 mil M | |
+28,03 % | 11,67 mil M |
- Bolsa de valores
- Acciones
- Acción BDTX
- Acción BDTX
- Empresa Black Diamond Therapeutics, Inc.